These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38844365)

  • 61. Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity.
    Roth Flach RJ; DiStefano MT; Danai LV; Senol-Cosar O; Yawe JC; Kelly M; Garcia Menendez L; Czech MP
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E303-E313. PubMed ID: 28611026
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MAP4K4/JNK Signaling Pathway Stimulates Proliferation and Suppresses Apoptosis of Human Spermatogonial Stem Cells and Lower Level of MAP4K4 Is Associated with Male Infertility.
    Wan C; Chen W; Cui Y; He Z
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497065
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of the Role of MAP4K4 in Focal Adhesion Dynamics and Regulation of Cell Migration of Breast Cancer Cell Line MDA-MB-231.
    Al-Fahad D; Al-Bedhawi M; Ateya H
    Arch Razi Inst; 2023 Feb; 78(1):261-267. PubMed ID: 37312710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4.
    Xie D; Li S; Wu T; Wang X; Fang L
    Pathol Res Pract; 2022 Feb; 230():153763. PubMed ID: 35026645
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MAP4K4 and cancer: ready for the main stage?
    González-Montero J; Rojas CI; Burotto M
    Front Oncol; 2023; 13():1162835. PubMed ID: 37223681
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
    Vitorino P; Yeung S; Crow A; Bakke J; Smyczek T; West K; McNamara E; Eastham-Anderson J; Gould S; Harris SF; Ndubaku C; Ye W
    Nature; 2015 Mar; 519(7544):425-30. PubMed ID: 25799996
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization.
    Crawford TD; Ndubaku CO; Chen H; Boggs JW; Bravo BJ; Delatorre K; Giannetti AM; Gould SE; Harris SF; Magnuson SR; McNamara E; Murray LJ; Nonomiya J; Sambrone A; Schmidt S; Smyczek T; Stanley M; Vitorino P; Wang L; West K; Wu P; Ye W
    J Med Chem; 2014 Apr; 57(8):3484-93. PubMed ID: 24673130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4.
    Schröder P; Förster T; Kleine S; Becker C; Richters A; Ziegler S; Rauh D; Kumar K; Waldmann H
    Angew Chem Int Ed Engl; 2015 Oct; 54(42):12398-403. PubMed ID: 25908259
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy.
    Chen W; Zhang J; Zhang P; Hu F; Jiang T; Gu J; Chang Q
    FASEB J; 2019 Mar; 33(3):3451-3464. PubMed ID: 30475644
    [TBL] [Abstract][Full Text] [Related]  

  • 71. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
    Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
    Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia.
    Roth Flach RJ; Danai LV; DiStefano MT; Kelly M; Menendez LG; Jurczyk A; Sharma RB; Jung DY; Kim JH; Kim JK; Bortell R; Alonso LC; Czech MP
    J Biol Chem; 2016 Jul; 291(31):16221-30. PubMed ID: 27226575
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.
    Chang CD; Chao MW; Lee HY; Liu YT; Tu HJ; Lien ST; Lin TE; Sung TY; Yen SC; Huang SH; Hsu KC; Pan SL
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2166039. PubMed ID: 36683274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Common Genetic Variants in Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 with Type 2 Diabetes Mellitus in a Chinese Han Population.
    Li TT; Qiao H; Tong HX; Zhuang TW; Wang TT
    Chin Med J (Engl); 2016 May; 129(10):1179-84. PubMed ID: 27174326
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety.
    Dow RL; Ammirati M; Bagley SW; Bhattacharya SK; Buckbinder L; Cortes C; El-Kattan AF; Ford K; Freeman GB; Guimarães CRW; Liu S; Niosi M; Skoura A; Tess D
    J Med Chem; 2018 Apr; 61(7):3114-3125. PubMed ID: 29570292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
    Aouadi M; Tesz GJ; Nicoloro SM; Wang M; Chouinard M; Soto E; Ostroff GR; Czech MP
    Nature; 2009 Apr; 458(7242):1180-4. PubMed ID: 19407801
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion.
    Migliavacca J; Züllig B; Capdeville C; Grotzer MA; Baumgartner M
    Commun Biol; 2022 Aug; 5(1):795. PubMed ID: 35941177
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer.
    Jovanovic D; Yan S; Baumgartner M
    Front Oncol; 2022; 12():1059513. PubMed ID: 36568222
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation.
    Yokoyama T; Nakamura T
    Cancer Sci; 2011 Jun; 102(6):1115-22. PubMed ID: 21338441
    [TBL] [Abstract][Full Text] [Related]  

  • 80. STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.
    Kim JW; Berrios C; Kim M; Schade AE; Adelmant G; Yeerna H; Damato E; Iniguez AB; Florens L; Washburn MP; Stegmaier K; Gray NS; Tamayo P; Gjoerup O; Marto JA; DeCaprio J; Hahn WC
    Elife; 2020 Jan; 9():. PubMed ID: 31913126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.